热门资讯> 正文
TC BioPharm Regains Compliance With Nasdaq Listing Rules
2024-08-16 01:42
01:42 PM EDT, 08/15/2024 (MT Newswires) -- TC BioPharm (TCBP) claimed Thursday it regained compliance with Nasdaq's minimum stockholders' equity requirement for continued listing of its American depositary shares.
The company believes it became compliant with the listing rules after closing certain transactions.
The bourse had approved Aug. 1, the biotech company's request to keep its listing if it met the requirement by Thursday.
Price: 3.43, Change: +0.10, Percent Change: +3.00
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
